1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United Kingdom Pharmaceuticals and Healthcare Report Q4 2016

United Kingdom Pharmaceuticals and Healthcare Report Q4 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 102 pages

Includes 3 FREE quarterly updates

BMI View: While the UK government's immediate focus will be on negotiating favourable terms for tradingand working with the EU after Brexit, the impact on health and social care will be a key topic of discussion.A slowdown in UK GDP growth and a drop in consumer demand does not necessarily signal a reduction inhealth spending, particularly as the government is committed to the NHS and a large number of patientswill continue to purchase private healthcare services over the pressured public sector. However, if aneconomic shock materialises and the government places financial pressures on the NHS, certain areas ofthe healthcare sector will suffer.

Headline Expenditure Projections

- Pharmaceuticals: GBP32.55bn (USD49.75bn) in 2015 to GBP33.75bn (USD44.12bn) in 2016; +3.7%in local currency terms and -11.3% in US dollar terms.

- Healthcare: GBP157.26bn (USD240.32bn) in 2015 to GBP160.84bn (USD210.25bn) in 2016; +2.3% inlocal currency terms and -12.5% in US dollar terms.

Table Of Contents

United Kingdom Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United Kingdom 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Kingdom 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 24
Generic Drug Market Forecast 25
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (United Kingdom 2014-2020) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (United Kingdom 2014-2020) 33
Industry Risk Reward Index 34
Western Europe Risk/Reward Index 34
United Kingdom Risk/Reward Index 40
Rewards 40
Risks 40
Regulatory Review 42
Intellectual Property Issues 42
Pricing Regime 44
Reimbursement Regime 49
Market Overview 50
Healthcare Sector 51
Table: Healthcare Resources (United Kingdom 2010-2015) 56
Table: Healthcare Personnel (United Kingdom 2010-2015) 57
Table: Healthcare Activity (United Kingdom 2010-2015) 57
Research And Development 57
Clinical Trials 62
Epidemiology 63
Competitive Landscape 66
Research-Based Industry 66
Table: Multinational Market Activity 68
Pharmaceutical Distribution 69
Pharmaceutical Retail Sector 70
Company Profile 71
GlaxoSmithKline 71
AstraZeneca 77
Pfizer 82
Novartis 85
Sanofi 88
Demographic Forecast 91
Table: Population Headline Indicators (United Kingdom 1990-2025) 92
Table: Key Population Ratios (United Kingdom 1990-2025) 92
Table: Urban/Rural Population and Life Expectancy (United Kingdom 1990-2025) 93
Table: Population By Age Group (United Kingdom 1990-2025) 93
Table: Population By Age Group % (United Kingdom 1990-2025) 94
Glossary 96
Methodology 98
Pharmaceutical Expenditure Forecast Model 98
Healthcare Expenditure Forecast Model 98
Notes On Methodology 99
Risk/Reward Index Methodology 100
Index Overview 101
Table: Pharmaceutical Risk/Reward Index Indicators 101
Indicator Weightings 102

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.